At a glance
ClinicalIndex Comparison RecordN/ACompleted· 482 enrolled
Drug / intervention
Somatropindrug
Likely dose
Somatropin 0.23 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
AN INVESTIGATION INTENDED TO EVALUATE THE LONG-TERM EFFICACY AND SAFETY OF GENOTROPIN IN CHILDREN WITH SGA DWARFISM WITHOUT EPIPHYSEAL CLOSURE. (RETROSPECTIVE STUDY)
In Brief
An observational study evaluating Somatropin for Small for Gestational Age (SGA). Completed, enrolled 482 participants.
Detailed Summary
The objective of this surveillance is to collect Safety and Effectiveness information for Long term Use of Somatropin for Patients with a Small for Gestational Age (SGA).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSmall for Gestational Age (SGA)
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 2013
Enrollment StartSep 2013
Primary CompletionFeb 2017
Study CompletionJun 2017
TodayJul 2026
First PostedJul 12, 2013
Enrollment StartSep 5, 2013
Primary CompletionFeb 28, 2017
Study CompletionJun 7, 2017
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 13.0 years ago
Interventions
Somatropindrug
0.23 mg to 0.48 mg/kg/week